{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:50:48Z","timestamp":1761562248817,"version":"3.37.3"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178685","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T17:43:27Z","timestamp":1496943807000},"page":"e0178685","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7677-3347","authenticated-orcid":true,"given":"Leona","family":"Dold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Luda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolynne","family":"Schwarze-Zander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Boesecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Dieter","family":"Nischalke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Christian","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen Kurt","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"ref1","first-page":"464","article-title":"Nonalcoholic fatty liver disease among HIV-infected persons","volume":"50","author":"N Crum-Cianflone","year":"2009"},{"key":"ref2","first-page":"183","article-title":"Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons","volume":"8","author":"N Crum-Cianflone","year":"2010"},{"key":"ref3","first-page":"1279","article-title":"Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients","volume":"28","author":"J Macias","year":"2014"},{"key":"ref4","first-page":"1569","article-title":"Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy","volume":"60","author":"CG Morse","year":"2015"},{"key":"ref5","first-page":"1198","article-title":"Increasing burden of liver disease in patients with HIV infection","volume":"377","author":"D Joshi","year":"2011"},{"key":"ref6","first-page":"1883","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"S Sookoian","year":"2011"},{"key":"ref7","first-page":"e27087","article-title":"The PNPLA3 rs738409 148M\/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis","volume":"6","author":"HD Nischalke","year":"2011"},{"key":"ref8","first-page":"86","article-title":"Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians","volume":"53","author":"F Stickel","year":"2011"},{"key":"ref9","first-page":"906","article-title":"Common polymorphism in the PNPLA3\/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease","volume":"55","author":"E Trepo","year":"2011"},{"key":"ref10","first-page":"1443","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"S Buch","year":"2015"},{"key":"ref11","first-page":"e1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"EK Speliotes","year":"2011"},{"key":"ref12","first-page":"1461","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"S Romeo","year":"2008"},{"key":"ref13","first-page":"21","article-title":"Variant in PNPLA3 is associated with alcoholic liver disease","volume":"42","author":"C Tian","year":"2010"},{"key":"ref14","first-page":"352","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"J Kozlitina","year":"2014"},{"key":"ref15","first-page":"270","article-title":"The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2","volume":"35","author":"QM Anstee","year":"2015"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Dold L BC, Luda C, Boesecke C, Schwarze-Zander C, Nischalke HD, Wasmuth J-C, Rockstroh JK, Spengler U. Single Nucleotide Polymorphisms associated with alimentary fatty liver disease are not genetic risk factors for treatment-associated hepatic steatosis in HIV patients on HAART. In. 2013 ed: Clinical Research in HIV AIDS and Prevention; 2013.","DOI":"10.14302\/issn.2324-7339.jcrhap-12-140"},{"key":"ref17","first-page":"13","article-title":"The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan","volume":"36","author":"M Sasso","year":"2012"},{"key":"ref18","first-page":"902","article-title":"Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography","volume":"32","author":"RP Myers","year":"2012"},{"key":"ref19","first-page":"e91987","article-title":"Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy","volume":"9","author":"T Karlas","year":"2014"},{"key":"ref20","first-page":"403","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study","volume":"55","author":"J Foucher","year":"2006"},{"key":"ref21","first-page":"835","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"L Castera","year":"2008"},{"key":"ref22","first-page":"421","article-title":"Natural selection and the de Finetti diagram","volume":"31","author":"C Cannings","year":"1968"},{"key":"ref23","first-page":"272","article-title":"Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease","volume":"46","author":"SA Polyzos","year":"2012"},{"key":"ref24","first-page":"869","article-title":"Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals","volume":"99","author":"YC Lin","year":"2014"},{"key":"ref25","first-page":"493413","article-title":"Role of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome","volume":"2013","author":"P Perez-Matute","year":"2013"},{"key":"ref26","first-page":"465","article-title":"Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV\/hepatitis C virus-coinfected patients","volume":"30","author":"MA Jimenez-Sousa","year":"2016"},{"key":"ref27","first-page":"6696","article-title":"The crystal structure, mutagenesis, and activity studies reveal that patatin is a lipid acyl hydrolase with a Ser-Asp catalytic dyad","volume":"42","author":"TJ Rydel","year":"2003"},{"key":"ref28","first-page":"1056","article-title":"A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans","volume":"52","author":"A Kotronen","year":"2009"},{"key":"ref29","first-page":"2616","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene","volume":"58","author":"K Kantartzis","year":"2009"},{"key":"ref30","first-page":"190","article-title":"Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent","volume":"34","author":"S Romeo","year":"2010"},{"key":"ref31","first-page":"8913","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"H Mahdessian","year":"2014"},{"key":"ref32","first-page":"355","article-title":"Transient Elastography for the Detection of Liver Damage in Patients with HIV","volume":"4","author":"A Sagir","year":"2015"},{"key":"ref33","first-page":"178","article-title":"A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity","volume":"98","author":"P Leon-Mimila","year":"2015"},{"key":"ref34","first-page":"330","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"QM Anstee","year":"2013"},{"key":"ref35","first-page":"295","article-title":"Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease","volume":"10","author":"JM Ahn","year":"2016"},{"article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study","year":"2015","author":"R Kwok","key":"ref36"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:35:38Z","timestamp":1589024138000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178685"}},"subtitle":[],"editor":[{"given":"Pavel","family":"Strnad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178685","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,6,8]]}}}